In patients with non-squamous NSCLC who had high PD-L1 expression, chemo-IC was conspicuously superior to ICI in terms of PFS (HR 0.63, 95% CI 0.43–0.92). The gene discussed is CD274; the disease is non-small cell lung carcinoma.